EN
登录

临床试验证明Ritual的HyaCera能在90天内减少细纹和皱纹

Clinical Trial Proves Ritual's HyaCera Reduces Fine Lines and Wrinkles in 90 Days

PR Newswire 等信源发布 2024-02-12 22:00

可切换为仅中文


The brand is committed to clinical trials on the finished formulas for all products by 2030, providing validated scientific evidence in a murky category  LOS ANGELES, Feb. 12, 2024 /PRNewswire/ -- Ritual, the traceable health and wellness brand working to raise the standard in the supplement industry, today announced the completion of its clinical trial on HyaCera™, the brand's daily skin support supplement.

该品牌致力于到2030年对所有产品的成品配方进行临床试验,在一个阴暗的类别中提供经过验证的科学证据。洛杉矶,2024年2月12日/PRNewswire/--Rirty,一个致力于提高补充剂行业标准的可追溯健康和健康品牌,今天宣布完成其在HyaCera™上的临床试验,该品牌的每日皮肤支持补充剂。

The clinical study conducted in partnership with a leading research organization shows that Ritual's HyaCera™ is proven to reduce wrinkles and fine lines and improve skin smoothness in 90 days..

与一家领先研究机构合作进行的临床研究表明,Riture的HyaCera™被证明可以在90天内减少皱纹和细纹,改善皮肤光滑度。。

Continue Reading

继续阅读

HyaCera Before and After

透明果前后

HyaCera Before and After

透明果前后

'Selecting evidence-based ingredients has always been a priority for Ritual, and conducting a gold-standard clinical trial on the finished formula for HyaCera takes that commitment one step further. It provides robust scientific evidence on the efficacy of a skin supplement, a category that previously has had limited clinical support,' said Dr.

“选择循证成分一直是仪式的优先事项,对透明果的成品配方进行金标准临床试验将这一承诺进一步推进了一步。它为皮肤补充剂的功效提供了强有力的科学证据,而皮肤补充剂以前的临床支持有限。

Mastaneh Sharafi PhD RD, Vice President of Scientific and Clinical Affairs at Ritual. 'This clinical study not only reaffirms our dedication to producing high-quality products but also ensures that our customers can trust in the validated benefits of HyaCera™.'.

Mastaneh Sharafi博士,Riture公司科学和临床事务副总裁这项临床研究不仅重申了我们致力于生产高质量产品的决心,而且还确保了我们的客户可以信任HyaCera™的有效益处。

The randomized, double-blind, placebo-controlled design, widely acknowledged as the gold standard in human research, spanned a duration of 12 weeks. Participants were 63 healthy women and men ranging in age from 26 to 64. Multiple skin-related assessments were made at baseline, 4 weeks, 8 weeks, and 12 weeks after the commencement of the supplementation protocol.

这项随机、双盲、安慰剂对照的设计持续了12周,被广泛认为是人类研究的金标准。参与者是63名健康的女性和男性,年龄从26岁到64岁不等。在补充方案开始后的基线,4周,8周和12周进行了多次皮肤相关评估。

At 12 weeks, results include:.

在12周时,结果包括:。

A 356% reduction in crow's feet wrinkles within 90 days when compared to placebo.*

与安慰剂相比,90天内鱼尾纹减少了356%*

A 290% increase in facial skin smoothness within 90 days when compared to placebo.*

与安慰剂相比,90天内面部皮肤光滑度增加290%*

More HyaCera™ participants reported an improvement in skin elasticity, glow/radiance, fine lines and wrinkles and general signs of aging.*

更多的HyaCera™参与者报告说,皮肤弹性,光泽/光泽,细纹和皱纹以及衰老的一般迹象有所改善*

'We were highly skeptical of creating a product for this category. We reviewed numerous ingredients, but either found ingredients with clinical studies that were poorly conducted or ingredients with no clinical support at all,' said Adeline Grier-Welch MS, MPH, RDN, Senior Scientist at Ritual. 'We selected Ceratiq® and Hyabest® because they had human clinical evidence to support their efficacy, met our standards for traceability, and were ingredients we felt confident putting to the test in our own clinical trial.'Ingestible beauty is one of the fastest growing segments in the supplement category, predicted to reach 9.2 billion by the year 2031.

“我们对为这一类别创建产品持高度怀疑态度。“我们审查了许多成分,但要么发现了临床研究效果不佳的成分,要么发现了根本没有临床支持的成分,”Ririty高级科学家阿德琳·格里尔·韦尔奇(AdelineGrierWelch)说我们选择Ceratiq®和Hyabest®是因为它们有人类临床证据支持其功效,符合我们的可追溯性标准,并且是我们有信心在自己的临床试验中进行测试的成分。”可食美容是补充剂类别中增长最快的部分之一,预计到2031年将达到92亿。

Despite its rapid growth, very few products have human clinical trials to showcase proof and efficacy. 'It's important to me that we continue setting a new standard in the supplement industry. We've put a stake in the ground to conduct gold-standard human clinical trials in partnership with leading universities and research organizations from around the world on all our products by 2030,' said Katerina Schneider, Founder and CEO of Ritual.

尽管其快速增长,但很少有产品具有人体临床试验来展示证据和功效。“对我来说,重要的是我们要继续在补充剂行业制定新的标准。Rirty创始人兼首席执行官凯特琳娜·施耐德(KaterinaSchneider)说,我们已经与世界各地的顶尖大学和研究组织合作,在2030年之前对我们的所有产品进行金标准人体临床试验。

'This is not a requirement in the category, but it's something we believe is important to ensure our customers can feel confident in the efficacy of the products they are using everyday.'To date, Ritual has completed a university-led clinical trial on its Essential for Women 18+ formula, published in Frontiers In Nutrition — a leading, internationally recognized, peer- reviewed journal — and uses clinically studied key ingredients with strategic doses and forms across the rest of its line.

“这不是该类别的要求,但我们认为重要的是要确保我们的客户对他们每天使用的产品的功效充满信心。”迄今为止,Riture已经完成了一项由大学主导的针对其“女性必备”18+配方奶粉的临床试验,该试验发表在《营养学前沿》(Frontiers in Nutrition)——一本领先的、国际公认的同行评审期刊——上,并在其其他领域使用了临床研究的关键成分,其剂量和形式具有战略性。

The brand has also completed two in-vitro studies on Synbiotic+ and one in-vitro study on Essential for Women 18+.This announcement follows Ritual's request to Congress to define terms like 'clinically studi.

该品牌还完成了两项关于合生元+的体外研究和一项关于18岁以上女性必不可少的体外研究。这项宣布是在Ritle向国会提出定义“临床研究”等术语的要求之后发布的。